Global Impact of 2017 American Heart Association/American College of Cardiology Hypertension Guidelines: A Perspective from Japan

Kazuomi Kario

doi:10.1161/CIRCULATIONAHA.117.032851

Global Impact of 2017 American Heart Association/American College of Cardiology Hypertension Guidelines: A Perspective from Japan

Research output: Contribution to journal › Review article › peer-review

59 Scopus citations

Original language	English
Pages (from-to)	543-545
Number of pages	3
Journal	Circulation
Volume	137
Issue number	6
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.117.032851
State	Published - 6 Feb 2018
Externally published	Yes

Keywords

Japan
ambulatory
blood pressure monitoring

Access to Document

10.1161/CIRCULATIONAHA.117.032851

Cite this

@article{033d964063cb48809ad6b6c95300bc3f,

title = "Global Impact of 2017 American Heart Association/American College of Cardiology Hypertension Guidelines: A Perspective from Japan",

keywords = "Japan, ambulatory, blood pressure monitoring",

author = "Kazuomi Kario",

note = "Funding Information: Dr Kario received research funding from Teijin Pharma, Ltd; Omron Healthcare Co, Ltd; Fukuda Denshi; Bayer Yakuhin, Ltd; A&D Co, Ltd; Daiichi Sankyo Co, Ltd; Mochida Pharmaceutical Co, Ltd; EA Pharma; Boehringer Ingelheim Japan Inc; Tanabe Mitsubishi Pharma Corp; Shionogi & Co, Ltd; MSD KK; Sanwa Kagaku Kenkyusho Co, Ltd; and Bristol-Myers Squibb KK, as well as honoraria from Takeda Pharmaceutical Co, Ltd, and Omron Healthcare Co, Ltd.",

year = "2018",

month = feb,

day = "6",

doi = "10.1161/CIRCULATIONAHA.117.032851",

language = "English",

volume = "137",

pages = "543--545",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "6",

}

TY - JOUR

T1 - Global Impact of 2017 American Heart Association/American College of Cardiology Hypertension Guidelines

T2 - A Perspective from Japan

AU - Kario, Kazuomi

N1 - Funding Information: Dr Kario received research funding from Teijin Pharma, Ltd; Omron Healthcare Co, Ltd; Fukuda Denshi; Bayer Yakuhin, Ltd; A&D Co, Ltd; Daiichi Sankyo Co, Ltd; Mochida Pharmaceutical Co, Ltd; EA Pharma; Boehringer Ingelheim Japan Inc; Tanabe Mitsubishi Pharma Corp; Shionogi & Co, Ltd; MSD KK; Sanwa Kagaku Kenkyusho Co, Ltd; and Bristol-Myers Squibb KK, as well as honoraria from Takeda Pharmaceutical Co, Ltd, and Omron Healthcare Co, Ltd.

PY - 2018/2/6

Y1 - 2018/2/6

KW - Japan

KW - ambulatory

KW - blood pressure monitoring

UR - http://www.scopus.com/inward/record.url?scp=85048441812&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.117.032851

DO - 10.1161/CIRCULATIONAHA.117.032851

M3 - Review article

C2 - 29431656

AN - SCOPUS:85048441812

SN - 0009-7322

VL - 137

SP - 543

EP - 545

JO - Circulation

JF - Circulation

IS - 6

ER -